Press Release 15 Jul 2020 Autobahn Therapeutics Appoints Business Leader, Scott Forrest, Ph.D., as Chief Business Officer by autobahntx Read More
News 15 Jul 2020 Sehr gut: Autobahn roars out of stealth mode with $76M, new leitmotif in MS by autobahntx Read More
News 15 Jul 2020 ARCH-backed Autobahn launches with $76M to rebuild myelin and reverse MS by autobahntx Read More
Press Release 15 Jul 2020 Autobahn Therapeutics Launches with $76 Million Series B Financing to Develop Next Generation Therapies for CNS Disorders by autobahntx Read More
